FDA takes first step in possible reversal of ban on some peptides The Washington Post Emerging Use of BPC 157 in Orthopaedic Sports Medicine: A Systematic Review Nikhil Vasireddi, Henrik Hahamyan, Michael J. Salata, Michael Karns, Jacob G. Calcei, James E. Voos, John M. Apostolakos, 2025 In 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies. Now, under RFK Jr., the agency is poised to reverse itself despite the fact that few The Pharmacology of Longevity: Peptide Edition (Part 1) FDA to weigh easing limits on peptides promoted by RFK Jr. NBC 6 South Florida